Oncology Features

Cancer can take an enormous emotional toll on older people’s mental health. this article reports on what practitioners – whatever their specialty - can do to support them.

Studies support the widely held belief that early detection and treatment of cancer improves outcomes in terms of cure or prolonged survival. This is a retrospective survey of recent cancer diagnoses in a primary care setting analysing patient pathways to diagnosis.

Patients must currently consult with a primary care practitioner prior to being referred to secondary care breast services. This study aims to explore views on patient self-referral, evaluate the community breast workload, and to investigate the impact of Covid-19 on referral rates.

Even before the pandemic, uptake on women's screening programmes varied. What will healthcare professionals need to do when services begin running again to ensure women attend?

The prognosis for bladder cancer can vary significantly based on the stage and grade of the cancer. In the advanced stages, survival rates can be very poor. This article reviews new advances in bladder cancer that could improve patient outcomes.

Lack of awareness among patients of the signs and symptoms of lung cancer, and when to see their doctor, continues to be a core issue for lung cancer survival. 

Although most women are aware that a lump can be a sign of breast cancer, awareness of other potential signs and symptoms among the public are poor. This article discusses risk factors and presentation of breast cancer in primary care and treatment of early disease.

Around 7,100 women are diagnosed in the UK with ovarian cancer each year. Read the latest on developments in the diagnosis and management of ovarian cancer.

This section reviews the latest news and reports on medical advances including data from the European Society for Medical Oncology (ESMO) Congress held in Madrid, Spain.

The ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) features updates in the diagnosis, staging and prognosis assessment, treatment of loco-regional recurrence and metastatic disease, as well as treatment of specific breast cancer subtypes.